Audio By Carbonatix
Founder and Chief Executive Officer (CEO) of the COA Research and Manufacturing Company says his outfit is close to a research breakthrough in plant medicine from which the country could realise not less than $32 billion annually.
Prof Samuel Ato Duncan added that funds generated from the medicine would bring some economic relief to the country when it turns out successful.
Speaking at the re-launch of the COA Mixture on Wednesday, May 25, he added that the medicine can also offer treatment to some diseases the world is still struggling to treat.
“This is what I want to achieve for mother Ghana as part of my Global Peace Mission Project,” Prof Duncan explained.

He noted that the re-launched COA Mixture is an upgrade in drug development and after going through processes at the Food and Drugs Authority (FDA), it has been upgraded from a food supplement to a herbal medicine for general wellbeing.
However, “it is not an HIV and AIDS drug. COA Mixture is for healthy living; it is a 100 per cent natural product from plants and without any artificial preservatives.

“COA Mixture is one of the best medicines the world has ever produced because of the numerous evidence-based testimonies from users.”
Need for collaboration
Prof Samuel Duncan called on government, research institutions and investors to collaborate with the Company in order to make its visions achievable.
Although the Company has acquired 1,000 acres of land to cultivate raw materials in the Ashanti Region, he said they would need an additional 9,000 acres of lands to produce COA products that would meet international market demands.

A cash donation of ¢100,000 was made to the Ghana Federation of Traditional Medicine Practitioners Associations (GHAFTRAM) to help members go through some evaluation and registration processes for the certification of their medicines.
Prof Ato Duncan also appointed the Asantehene, Otumfuo Osei Tutu II to be the Patron of the COA Mixture because of his support for the product.
Pharmaceutical sector
The Trade and Industry Minister, Alan Kyerematen, revealed that government is investing in the pharmaceutical sector in the quest to diversify the economy.
“For the country to depend on only two commodities — cocoa and gold — for over 100 years is clearly not sustainable. So we need to diversify our economy.
“The country produces only about 30 per cent of our required medicines, so we import almost 70 per cent of our required drugs, which is unacceptable,” he posited.

The Trade Minister also used the opportunity to urge manufacturers to follow laid down protocols to build public confidence and get their products accepted.
“If you want to become like COA, you have to be able to subject your products to various processes, including therapeutic analysis.
“If you want to do mass production that will earn you income, then you need to expose your processes to technology,” he stressed.
Latest Stories
-
AWLA-Ghana holds consultative forum to shape National Family Law and Justice Conference
9 minutes -
Nigerian youths: Stop facebooking and face the book
12 minutes -
Leadership, Accountability, and the KATH CEO suspension: Reflections on Ghana’s healthcare governance
21 minutes -
Government repatriates 327 stranded Ghanaians from Côte d’Ivoire
39 minutes -
World Cup qualification will deliver significant economic benefits to Ghana
52 minutes -
ASEC urges major reforms after Akosombo Substation fire investigation
53 minutes -
NDC achieved democratic objective with presidential term limit—Majority Leader
57 minutes -
From Humble Beginnings to Public Service and the Global Stage: The journey of Emmanuel Kwame Agyemang
60 minutes -
Bank of Africa partners schools nationwide for tree planting, promotes financial inclusion through education
1 hour -
Inflation could be coming down due to expected harvest season – Government Statistician
1 hour -
Croatia World Cup 2026 team guide
1 hour -
England World Cup 2026 team guide
1 hour -
The Law 101 – Plea Deals: Justice made swifter and surer
1 hour -
Panama World Cup 2026 team guide
2 hours -
Middle East conflict sends global growth to lowest rate since COVID-19 – World Bank
2 hours